From the Department of Radiology (N.A.K., D.P.B.), Duke University Medical Center, Durham, North Carolina.
The Preston Robert Tisch Brain Tumor Center (A.D.), Duke University Medical Center, Durham, North Carolina.
AJNR Am J Neuroradiol. 2021 Jun;42(6):1080-1086. doi: 10.3174/ajnr.A7071. Epub 2021 Mar 18.
Despite high interest in machine-learning algorithms for automated segmentation of MRIs of patients with brain tumors, there are few reports on the variability of segmentation results. The purpose of this study was to obtain benchmark measures of repeatability for a widely accessible software program, BraTumIA (Versions 1.2 and 2.0), which uses a machine-learning algorithm to segment tumor features on contrast-enhanced brain MR imaging.
Automatic segmentation of enhancing tumor, tumor edema, nonenhancing tumor, and necrosis was performed on repeat MR imaging scans obtained approximately 2 days apart in 20 patients with recurrent glioblastoma. Measures of repeatability and spatial overlap, including repeatability and Dice coefficients, are reported.
Larger volumes of enhancing tumor were obtained on later compared with earlier scans (mean, 26.3 versus 24.2 mL for BraTumIA 1.2; < .05; and 24.9 versus 22.9 mL for BraTumIA 2.0, < .01). In terms of percentage change, repeatability coefficients ranged from 31% to 46% for enhancing tumor and edema components and from 87% to 116% for nonenhancing tumor and necrosis. Dice coefficients were highest (>0.7) for enhancing tumor and edema components, intermediate for necrosis, and lowest for nonenhancing tumor and did not differ between software versions. Enhancing tumor and tumor edema were smaller, and necrotic tumor larger using BraTumIA 2.0 rather than 1.2.
Repeatability and overlap metrics varied by segmentation type, with better performance for segmentations of enhancing tumor and tumor edema compared with other components. Incomplete washout of gadolinium contrast agents could account for increasing enhancing tumor volumes on later scans.
尽管人们对用于自动分割脑肿瘤患者 MRI 的机器学习算法很感兴趣,但有关分割结果可变性的报道却很少。本研究的目的是为广泛使用的软件程序 BraTumIA(版本 1.2 和 2.0)获得可重复的基准指标,该软件程序使用机器学习算法对对比度增强脑 MRI 上的肿瘤特征进行分割。
对 20 例复发性胶质母细胞瘤患者约 2 天重复的 MRI 扫描进行自动增强肿瘤、肿瘤水肿、非增强肿瘤和坏死的分割。报告了可重复性和空间重叠的度量标准,包括可重复性和 Dice 系数。
与早期扫描相比,晚期扫描获得的增强肿瘤体积更大(BraTumIA 1.2 为 26.3 与 24.2 mL, <.05;BraTumIA 2.0 为 24.9 与 22.9 mL, <.01)。就百分比变化而言,增强肿瘤和水肿成分的可重复性系数范围为 31%至 46%,而非增强肿瘤和坏死的可重复性系数范围为 87%至 116%。增强肿瘤和水肿成分的 Dice 系数最高(>0.7),坏死次之,非增强肿瘤最低,且两个软件版本之间无差异。与 BraTumIA 1.2 相比,BraTumIA 2.0 下的增强肿瘤和肿瘤水肿更小,坏死肿瘤更大。
可重复性和重叠度量标准因分割类型而异,增强肿瘤和肿瘤水肿的分割性能优于其他成分。钆对比剂不完全洗脱可能导致晚期扫描时增强肿瘤体积增加。